These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11939822)
1. Imiquimod and genital herpes. Slade HB; Schacker T; Conant M; Thoming C Arch Dermatol; 2002 Apr; 138(4):534; author reply 534-5. PubMed ID: 11939822 [No Abstract] [Full Text] [Related]
2. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases. Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057 [TBL] [Abstract][Full Text] [Related]
3. Extensive and refractory genital herpes in human immunodeficiency virus-infected patient successfully treated with imiquimod: Case report and literature review. Camasmie HR; Barbosa C; Lupi O; Lima RB; Serra M; D'Acri AM; Martins CJ Indian J Dermatol Venereol Leprol; 2017; 83(2):256-259. PubMed ID: 28164895 [No Abstract] [Full Text] [Related]
4. Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study. Schacker TW; Conant M; Thoming C; Stanczak T; Wang Z; Smith M Antimicrob Agents Chemother; 2002 Oct; 46(10):3243-8. PubMed ID: 12234851 [TBL] [Abstract][Full Text] [Related]
5. Current and potential uses of imiquimod. Chang YC; Madkan V; Cook-Norris R; Sra K; Tyring S South Med J; 2005 Sep; 98(9):914-20. PubMed ID: 16217984 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study. Leeyaphan C; Surawan TM; Chirachanakul P; Prasertworonun N; Punyaratabandhu P; Omcharoen V; Jiamton S Int J Infect Dis; 2015 Apr; 33():165-70. PubMed ID: 25660091 [TBL] [Abstract][Full Text] [Related]
7. Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs. Bernstein DI; Harrison CJ; Tepe ER; Shahwan A; Miller RL Vaccine; 1995 Jan; 13(1):72-6. PubMed ID: 7762282 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of hypertrophic herpes simplex genitalis in HIV-infected patient with topical imiquimod. Deza G; Martin-Ezquerra G; Curto-Barredo L; Villar García J; Pujol RM J Dermatol; 2015 Dec; 42(12):1176-8. PubMed ID: 26074211 [TBL] [Abstract][Full Text] [Related]
9. Immune booster used to fight drug-resistant herpes. TreatmentUpdate; 2001 Aug; 13(4):5. PubMed ID: 11590979 [No Abstract] [Full Text] [Related]
10. Chronic genital ulceration due to herpes simplex infection treated successfully with imiquimod. Bangsgaard N; Skov L Acta Derm Venereol; 2008; 88(2):202-3. PubMed ID: 18311468 [No Abstract] [Full Text] [Related]
11. Immunomodulation as a treatment strategy for genital herpes: review of the evidence. Miller RL; Tomai MA; Harrison CJ; Bernstein DI Int Immunopharmacol; 2002 Mar; 2(4):443-51. PubMed ID: 11962724 [TBL] [Abstract][Full Text] [Related]
12. Vegetative chronic genital herpes with satisfactory response to imiquimod. Siqueira SM; Gonçalves BB; Loss JB; Estrella RR An Bras Dermatol; 2019; 94(2):221-223. PubMed ID: 31090830 [TBL] [Abstract][Full Text] [Related]